Lee Yuchun's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Apr 6, 2022
- Accession no.
- 0000899243-22-014117
- Filed
- Apr 6, 2022
- Trade date
- Apr 4-5, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 11 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.08M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lee YuchunCIK 0001334365 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2022 | Common Stock | MOption exerciseAcquired | +2,000 | $81.54 | +$163,080 | 3,875 | Direct | |
| Apr 4, 2022 | Common Stock | SSaleDisposed | −100 | $265.83 | −$26,583 | 3,775 | Direct | |
| Apr 4, 2022 | Common Stock | SSaleDisposed | −917 | $267.23F2,F3 | −$245,049.91 | 2,858 | Direct | |
| Apr 4, 2022 | Common Stock | SSaleDisposed | −983 | $268.36F2,F4 | −$263,797.88 | 1,875 | Direct | |
| Apr 5, 2022 | Common Stock | MOption exerciseAcquired | +2,000 | $81.54 | +$163,080 | 3,875 | Direct | |
| Apr 5, 2022 | Common Stock | SSaleDisposed | −17 | $268.30 | −$4,561.1 | 3,858 | Direct | |
| Apr 5, 2022 | Common Stock | SSaleDisposed | −334 | $270.05F2,F5 | −$90,196.7 | 3,524 | Direct | |
| Apr 5, 2022 | Common Stock | SSaleDisposed | −488 | $271.94F2,F6 | −$132,706.72 | 3,036 | Direct | |
| Apr 5, 2022 | Common Stock | SSaleDisposed | −600 | $272.60F2,F7 | −$163,560 | 2,436 | Direct | |
| Apr 5, 2022 | Common Stock | SSaleDisposed | −100 | $273.50 | −$27,350 | 2,336 | Direct | |
| Apr 5, 2022 | Common Stock | SSaleDisposed | −461 | $274.66F2,F8 | −$126,618.26 | 1,875 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2022 | Common Stock | MOption exerciseDisposed | −2,000 | $81.54 | −$163,080 | 18,000 | Direct | |
| Apr 5, 2022 | Common Stock | MOption exerciseDisposed | −2,000 | $81.54 | −$163,080 | 16,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 6 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $267.23 (range $266.85 to $267.79).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $268.36 (range $267.97 to $268.81).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $270.05 (range $269.79 to $270.64).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $271.94 (range $271.35 to $272.27).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $272.60 (range $272.36 to $273.34).
Referenced by the price of 1 transaction in Table I.
- F8
Open market sales reported on this line occurred at a weighted average price of $274.66 (range $274.63 to $274.68).
Referenced by the price of 1 transaction in Table I.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney